Open menu
  • logo
  • CanadaCanada
  • Products
    • Search for Product
      • Product Name

        Keyword Search

    • Featured Products
        • KETAMALT 50

          Ketamalt® 50

        • TILCOMED


  • News
  • Library
  • Facilities
  • Regions
  • Contacts

Bimeda-MTC announces the addition of TilcoMed to their line-up.

Cambridge, Ontario (July 20, 2015): now available from Bimeda-MTC: TilcoMed (Tilmicosin Injection USP, 300 mg/mL) an antibiotic to treat Bovine Respiratory Disease in beef cattle as well as Pneumonic Pasteurellosis in lambs. DIN 02435861, Approved by Health Canada.

TilcoMed is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia (Pasturella) haemolytica and Pasteurella multocida. For the reduction of morbidity associated with bovine respiratory disease (BRD) in feedlot calves, caused by Mannheimia (Pasturella) haemolytica and Pasteurella multocida, during the first 30 days in the feedlot, when administered at the time of arrival.

Also for the treatment of pneumonic pasteurellosis in lambs associated with Mannheimia (Pasteurella) haemolytica.

Not intended for use in lactating dairy cows.

Do not administer intravenously.

Do not administer to swine. Injection can be fatal.

Not for human use. Human injection has been associated with fatalities.

For further information visit or email This email address is being protected from spambots. You need JavaScript enabled to view it.